Machine Learning-Assisted Ensemble Analysis for the Prediction of Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer

被引:2
作者
Huang, Yibao [1 ]
Zhu, Qingqing [1 ]
Xue, Liru [1 ]
Zhu, Xiaoran [1 ]
Chen, Yingying [1 ]
Wu, Mingfu [1 ]
机构
[1] Huazhong Univ Sci & Technol, Natl Clin Res Ctr Obstetr & Gynecol Dis, Key Lab Canc Invas & Metastasis, Tongji Hosp,Tongji Med Coll,Dept Gynecol,Minist E, Wuhan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
locally advanced cervical cancer; neoadjuvant chemotherapy; machine learning analysis; predictive model; pathology response; INFLAMMATION MARKERS; RADICAL HYSTERECTOMY; CURATIVE RESECTION; SURGERY; VALIDATION; FIBRINOGEN; EFFICACY;
D O I
10.3389/fonc.2022.817250
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The clinical benefit of neoadjuvant chemotherapy (NACT) before concurrent chemoradiotherapy (CCRT) vs. adjuvant chemotherapy after CCRT is debated. Non-response to platinum-based NACT is a major contributor to poor prognosis, but there is currently no reliable method for predicting the response to NACT (rNACT) in patients with locally advanced cervical cancer (LACC). In this study we developed a machine learning (ML)-assisted model to accurately predict rNACT. We retrospectively analyzed data on 636 patients diagnosed with stage IB2 to IIA2 cervical cancer at our hospital between January 1, 2010 and December 1, 2020. Five ML-assisted models were developed from candidate clinical features using 2-step estimation methods. Receiver operating characteristic curve (ROC), clinical impact curve, and decision curve analyses were performed to evaluate the robustness and clinical applicability of each model. A total of 30 candidate variables were ultimately included in the rNACT prediction model. The areas under the ROC curve of models constructed using the random forest classifier (RFC), support vector machine, eXtreme gradient boosting, artificial neural network, and decision tree ranged from 0.682 to 0.847. The RFC model had the highest predictive accuracy, which was achieved by incorporating inflammatory factors such as platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, neutrophil-to-albumin ratio, and lymphocyte-to-monocyte ratio. These results demonstrate that the ML-based prediction model developed using the RFC can be used to identify LACC patients who are likely to respond to rNACT, which can guide treatment selection and improve clinical outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Machine learning for genetic prediction of chemotherapy toxicity in cervical cancer
    Guo, Lu
    Wang, Wei
    Xie, Xiaodong
    Wang, Shuihua
    Zhang, Yudong
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [22] Meta-analysis of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer
    Wang, Daying
    Fang, Xiuli
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 297 : 202 - 208
  • [23] Prediction model of objective response after neoadjuvant chemotherapy in patients with locally advanced gastric cancer
    Xu, Wei
    Fan, Zhiyuan
    Wang, Lingquan
    He, Changyu
    Ni, Zhentian
    Hua, Zichen
    Zhu, Zhenglun
    Yang, Zhongyin
    Zheng, Yanan
    Feng, Runhua
    Yan, Chao
    Li, Chen
    Yao, Xuexin
    Chen, Mingmin
    Yan, Min
    Zhu, Zhenggang
    Liu, Wentao
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (03): : 1568 - 1579
  • [24] Neoadjuvant chemotherapy in woman with early or locally advanced cervical cancer
    de la Torre, Marcela
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2018, 23 (06) : 528 - 532
  • [25] Development and Validation of a Nomogram for the Estimation of Response to Platinum-Based Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Cancer
    Chen, Wei
    Wang, Bo
    Zeng, Rong
    Wang, Tiejun
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1279 - 1289
  • [26] Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy
    Arezzo, Francesca
    Cormio, Gennaro
    Mongelli, Michele
    Cazzato, Gerardo
    Silvestris, Erica
    Kardhashi, Anila
    Cazzolla, Ambrogio
    Lombardi, Claudio
    Venerito, Vincenzo
    Loizzi, Vera
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2023, 307 (06) : 1911 - 1919
  • [27] The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study
    Yang, Zhijun
    Chen, Dandan
    Zhang, Jieqing
    Yao, Desheng
    Gao, Kun
    Wang, He
    Liu, Cui
    Yu, Jiang
    Li, Li
    GYNECOLOGIC ONCOLOGY, 2016, 141 (02) : 231 - 239
  • [28] Effectiveness of neoadjuvant chemotherapy followed by radical surgery in young patients with locally advanced cervical cancer
    Gong, Lin
    Yin, Ru-Tie
    Li, Qing-Li
    Bian, Ce
    Peng, Zhi-Lan
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (01) : 26 - 33
  • [29] The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer
    Qu, Jianjun
    Qu, Xiangyang
    CANCER BIOMARKERS, 2016, 17 (01) : 49 - 54
  • [30] EARLY PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER USING MRI
    Kawamura, Mariko
    Satake, Hiroko
    Ishigaki, Satoko
    Nishio, Akiko
    Sawaki, Masataka
    Naganawa, Shinji
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2011, 73 (3-4): : 147 - 156